Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients

Acute myeloid leukemia (AML) is a heterogeneous disease with different clinical course and prognosis. microRNA-29 (miR-29) family of non-coding small RNAs can play an important role in pathogenesis of AML, but also can influence response to therapy. The purpose of the study was to evaluate miR-29c e...

Descripción completa

Detalles Bibliográficos
Autores principales: Butrym, Aleksandra, Rybka, Justyna, Baczyńska, Dagmara, Poręba, Rafał, Kuliczkowski, Kazimierz, Mazur, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058678/
https://www.ncbi.nlm.nih.gov/pubmed/26862847
http://dx.doi.org/10.18632/oncotarget.7172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058678/
https://www.ncbi.nlm.nih.gov/pubmed/26862847
http://dx.doi.org/10.18632/oncotarget.7172

Ejemplares similares